These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 33393779)
1. Evaluation of Recombinant CYP3A4 Variants on the Metabolism of Oxycodone In Vitro. Cai Y; Lin Q; Jin Z; Xia F; Ye Y; Xia Y; Papadimos TJ; Wang Q; Hu G; Cai J; Chen L Chem Res Toxicol; 2021 Jan; 34(1):103-109. PubMed ID: 33393779 [TBL] [Abstract][Full Text] [Related]
2. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism. Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574 [TBL] [Abstract][Full Text] [Related]
3. Functional assessment of Fang P; Tang PF; Xu RA; Zheng X; Wen J; Bao SS; Cai JP; Hu GX Drug Des Devel Ther; 2017; 11():3503-3510. PubMed ID: 29263648 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro. Yang CC; Zheng X; Liu TH; Wang CC; Tang PF; Chen Z; Zhang BW; Fang P; Hu GX; Cai JP Xenobiotica; 2019 Jan; 49(1):120-126. PubMed ID: 29394111 [TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors. Moody DE; Liu F; Fang WB J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299 [TBL] [Abstract][Full Text] [Related]
6. Functional assessment of the effects of CYP3A4 variants on acalabrutinib metabolism in vitro. Han M; Qian J; Ye Z; Xu R; Chen D; Xie S; Cai J; Hu G Chem Biol Interact; 2021 Aug; 345():109559. PubMed ID: 34153224 [TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro. Xu RA; Wen J; Tang P; Wang C; Xie S; Zhang BW; Zhou Q; Cai JP; Hu GX Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):383-387. PubMed ID: 29117640 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro. Li YH; Lin QM; Pang NH; Zhang XD; Huang HL; Cai JP; Hu GX Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):337-344. PubMed ID: 31058459 [TBL] [Abstract][Full Text] [Related]
9. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications. Fang WB; Lofwall MR; Walsh SL; Moody DE J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505 [TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro. Han M; Zhang X; Ye Z; Wang J; Qian J; Hu G; Cai J Chem Biol Interact; 2021 Dec; 350():109700. PubMed ID: 34648813 [TBL] [Abstract][Full Text] [Related]
11. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Lalovic B; Phillips B; Risler LL; Howald W; Shen DD Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299 [TBL] [Abstract][Full Text] [Related]
12. Effects of 26 Recombinant CYP3A4 Variants on Brexpiprazole Metabolism. Chen B; Zhang XD; Wen J; Zhang B; Chen D; Wang S; Cai JP; Hu GX Chem Res Toxicol; 2020 Jan; 33(1):172-180. PubMed ID: 31560202 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel substrates for human cytochrome P450 2J2. Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro. Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917 [TBL] [Abstract][Full Text] [Related]
15. Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro. Xie SL; Zhu X; Gao N; Lin Q; Chen C; Yang YJ; Cai JP; Hu GX; Xu RA Food Chem Toxicol; 2023 Nov; 181():114101. PubMed ID: 37863381 [TBL] [Abstract][Full Text] [Related]
16. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. Moody DE; Liu F; Fang WB J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of 27 CYP3A4 variants on macitentan metabolism in vitro. Li YH; Lu XR; Lin QM; Huang HL; Liang XL; Cai JP; Cui J; Hu GX J Pharm Pharmacol; 2019 Nov; 71(11):1677-1683. PubMed ID: 31441067 [TBL] [Abstract][Full Text] [Related]
18. Observations of urinary oxycodone and metabolite distributions in pain patients. Elder NM; Atayee RS; Best BM; Ma JD J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296 [TBL] [Abstract][Full Text] [Related]
19. Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro. Liu Q; Ou-Yang QG; Lin QM; Lu XR; Ma YQ; Li YH; Xu RA; Lin DD; Hu GX; Cai JP Fundam Clin Pharmacol; 2022 Feb; 36(1):150-159. PubMed ID: 33961299 [TBL] [Abstract][Full Text] [Related]
20. Functional Analysis of Wild-Type and 27 CYP3A4 Variants on Dronedarone Metabolism Wang CC; Lan T Curr Drug Metab; 2022; 23(7):562-570. PubMed ID: 35702776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]